These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20875336)

  • 1. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 4. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 6. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment.
    Mancini G; Erario L; Gianfreda R; Oliva A; Massetti AP; Mastroianni CM; Vullo V
    Clin Microbiol Infect; 2007 Oct; 13(10):1036-7. PubMed ID: 17711485
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
    Geissal ED; Wernick R
    J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasiform eruption associated with alopecia areata during infliximab therapy.
    Nakagomi D; Harada K; Yagasaki A; Kawamura T; Shibagaki N; Shimada S
    Clin Exp Dermatol; 2009 Dec; 34(8):923-4. PubMed ID: 19438542
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of alopecia areata universalis in a patient receiving adalimumab.
    Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
    Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
    [No Abstract]   [Full Text] [Related]  

  • 12. Alopecia areata in a patient receiving infliximab.
    Ormaechea-Pérez N; López-Pestaña A; Muñagorri-Santos AI; Moreno AJ; Tuneu-Valls A
    Indian J Dermatol Venereol Leprol; 2013; 79(4):529-31. PubMed ID: 23760327
    [No Abstract]   [Full Text] [Related]  

  • 13. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
    Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
    Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
    Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 18. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: Report of five cases and review of the literature.
    Ferran M; Calvet J; Almirall M; Pujol RM; Maymó J
    J Eur Acad Dermatol Venereol; 2011 Apr; 25(4):479-84. PubMed ID: 20586836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
    Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
    Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
    Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
    J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.